Ginkgo Bioworks Holdings Stock Performance

DNA Stock  USD 9.41  0.01  0.11%   
The company retains a Market Volatility (i.e., Beta) of 0.66, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Ginkgo Bioworks' returns are expected to increase less than the market. However, during the bear market, the loss of holding Ginkgo Bioworks is expected to be smaller as well. Ginkgo Bioworks Holdings right now retains a risk of 5.0%. Please check out Ginkgo Bioworks total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Ginkgo Bioworks will be following its current trending patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Ginkgo Bioworks Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Ginkgo Bioworks is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more

Actual Historical Performance (%)

One Day Return
5.87
Five Day Return
(1.78)
Year To Date Return
7.82
Ten Year Return
(97.68)
All Time Return
(97.68)
Last Split Factor
1:40
Last Split Date
2024-08-20
1
Woman reunites with long-lost dad after 27 years by tracking him down on Facebook
11/28/2025
2
Disposition of 1244 shares by Mark Dmytruk of Ginkgo Bioworks at 7.283 subject to Rule 16b-3
12/01/2025
3
Disposition of 312 shares by Coen Steven P. of Ginkgo Bioworks subject to Rule 16b-3
12/12/2025
4
DNA My Dog Releases Annual List of 2025s Most Popular Dog Names
12/16/2025
5
Making a stink NJ condo busts residents who fail to pick up dog poop by testing it for DNA
01/14/2026
6
Disposition of 587 shares by Coen Steven P. of Ginkgo Bioworks subject to Rule 16b-3
01/16/2026
7
Ginkgo Bioworks Holdings, Inc. Stock Drops Despite Market Gains Important Facts to Note - Yahoo Finance
01/23/2026
8
Metaverse Dualchain Network Architecture Price Reaches 0.0000 on Exchanges
01/28/2026
9
Ginkgo Bioworks Autonomous Laboratory Driven by OpenAIs GPT-5 Achieves 40 percent Improvement Over State-of-the-Art Scientific Benchmark
02/05/2026
10
Ginkgo, OpenAI Cut Protein Costs by 40
02/06/2026
11
New England Biolabs launches Monarch Mag Cell-free DNA Extraction Kit to enable scalable, reproducible cfDNA isolation from biofluids
02/12/2026
12
What screening did Christy Carlson Romano use to test positive for cancer and should everyone be getting one
02/18/2026
13
iMused Marks First Official Platform Song Release With The Bag, Written by CLEO-P Using Arya Starrs Musical DNA as the Muse Source
02/19/2026
14
Desperate federal investigators weigh using DNA genealogy websites for Nancy Guthrie case
02/20/2026
15
Acquisition by Coen Steven P. of 1174 shares of Ginkgo Bioworks subject to Rule 16b-3
02/24/2026
Begin Period Cash Flow989.6 M
Total Cashflows From Investing Activities-62.2 M

Ginkgo Bioworks Relative Risk vs. Return Landscape

If you would invest  928.00  in Ginkgo Bioworks Holdings on November 28, 2025 and sell it today you would lose (42.00) from holding Ginkgo Bioworks Holdings or give up 4.53% of portfolio value over 90 days. Ginkgo Bioworks Holdings is generating 0.0415% of daily returns assuming volatility of 5.0046% on return distribution over 90 days investment horizon. In other words, 44% of stocks are less volatile than Ginkgo, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Ginkgo Bioworks is expected to generate 1.53 times less return on investment than the market. In addition to that, the company is 6.57 times more volatile than its market benchmark. It trades about 0.01 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Ginkgo Bioworks Target Price Odds to finish over Current Price

The tendency of Ginkgo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 9.41 90 days 9.41 
about 27.53
Based on a normal probability distribution, the odds of Ginkgo Bioworks to move above the current price in 90 days from now is about 27.53 (This Ginkgo Bioworks Holdings probability density function shows the probability of Ginkgo Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Ginkgo Bioworks has a beta of 0.66 suggesting as returns on the market go up, Ginkgo Bioworks average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ginkgo Bioworks Holdings will be expected to be much smaller as well. Additionally Ginkgo Bioworks Holdings has an alpha of 0.2253, implying that it can generate a 0.23 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Ginkgo Bioworks Price Density   
       Price  

Predictive Modules for Ginkgo Bioworks

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ginkgo Bioworks Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
3.878.8713.87
Details
Intrinsic
Valuation
LowRealHigh
3.848.8413.84
Details
Naive
Forecast
LowNextHigh
4.549.5414.55
Details
6 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details

Ginkgo Bioworks Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Ginkgo Bioworks is not an exception. The market had few large corrections towards the Ginkgo Bioworks' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ginkgo Bioworks Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ginkgo Bioworks within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.23
β
Beta against Dow Jones0.66
σ
Overall volatility
0.62
Ir
Information ratio 0.04

Ginkgo Bioworks Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ginkgo Bioworks for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ginkgo Bioworks Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Ginkgo Bioworks had very high historical volatility over the last 90 days
Ginkgo Bioworks has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 227.04 M. Reported Net Loss for the year was (547.03 M) with profit before taxes, overhead, and interest of 131.31 M.
Ginkgo Bioworks Holdings has about 561.57 M in cash with (319.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84.
Ginkgo Bioworks has a poor financial position based on the latest SEC disclosures
Roughly 75.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Acquisition by Coen Steven P. of 1174 shares of Ginkgo Bioworks subject to Rule 16b-3

Ginkgo Bioworks Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ginkgo Stock often depends not only on the future outlook of the current and potential Ginkgo Bioworks' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ginkgo Bioworks' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding51.9 M
Cash And Short Term Investments561.6 M

Ginkgo Bioworks Fundamentals Growth

Ginkgo Stock prices reflect investors' perceptions of the future prospects and financial health of Ginkgo Bioworks, and Ginkgo Bioworks fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ginkgo Stock performance.

About Ginkgo Bioworks Performance

By analyzing Ginkgo Bioworks' fundamental ratios, stakeholders can gain valuable insights into Ginkgo Bioworks' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ginkgo Bioworks has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ginkgo Bioworks has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 0.36  0.34 
Return On Tangible Assets(0.48)(0.51)
Return On Capital Employed(0.51)(0.53)
Return On Assets(0.46)(0.48)
Return On Equity(0.88)(0.92)

Things to note about Ginkgo Bioworks Holdings performance evaluation

Checking the ongoing alerts about Ginkgo Bioworks for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Ginkgo Bioworks Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Ginkgo Bioworks had very high historical volatility over the last 90 days
Ginkgo Bioworks has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 227.04 M. Reported Net Loss for the year was (547.03 M) with profit before taxes, overhead, and interest of 131.31 M.
Ginkgo Bioworks Holdings has about 561.57 M in cash with (319.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84.
Ginkgo Bioworks has a poor financial position based on the latest SEC disclosures
Roughly 75.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Acquisition by Coen Steven P. of 1174 shares of Ginkgo Bioworks subject to Rule 16b-3
Evaluating Ginkgo Bioworks' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Ginkgo Bioworks' stock performance include:
  • Analyzing Ginkgo Bioworks' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ginkgo Bioworks' stock is overvalued or undervalued compared to its peers.
  • Examining Ginkgo Bioworks' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Ginkgo Bioworks' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ginkgo Bioworks' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Ginkgo Bioworks' stock. These opinions can provide insight into Ginkgo Bioworks' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Ginkgo Bioworks' stock performance is not an exact science, and many factors can impact Ginkgo Bioworks' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Ginkgo Stock analysis

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals